ULURU Inc. Reports First Quarter 2008 Financi...(nceof an unanticipated event. Further ma...),Health

Date:5/12/2008

nce of an unanticipated event. Further, management cannot assess the impact of each such factor on the business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. These statements are subject to numerous risks and uncertainties, including but not limited to the risk factors detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2007 and other reports filed by us with the Securities and Exchange Commission.

ULURU Inc.

SUMMARY OF RESULTS

STATEMENTS OF OPERATIONS DATA

(Unaudited)

Three Months Ended

March 31,

2008 2007

REVENUES

License fees $13,771 $138,050

Royalty income 75,574 55,461

Product sales 166,473 ---

Other --- 190,000

Total Revenues 255,818 383,511

COSTS AND EXPENSES

Cost of goods sold 137,614 ---

Research and development 875,216 565,408

General and administrative 893,235 595,239

Amortization 269,185 265,543

Depreciation 20,272 16,703

Total Costs and Expenses 2,195,522 1,442,893

OPERATING (LOSS) (1,939,704) (1,059,382)

Other Income (Expense)

Interest and miscellaneous income
'/>"/>

SOURCE ULURU Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. ULURU Inc. Announces the Launch Plan for Altrazeal(TM)
2. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter Ended December 31, 2007 and Provide a Business Update
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the First Quarter Ended March 31, 2008 and Provide a Business Update
4. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
5. ULURU Inc. Announces Issuance of Notice of Allowance for Nanoparticle Aggregate Patent
6. ULURU Inc. Reports Third Quarter 2007 Results
7. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2007 and Provide a Business Update
8. ULURU Inc. Announces Odd-Lot Buy Back Offer
9. ULURU Inc. to Present at UBS Global Life Sciences Conference 2007
10. Novadaq Reports Financial Results for the First Quarter of 2008
11. Isis Reports Financial Results and Highlights for First Quarter of 2008